Suppr超能文献

早、中期年龄相关性黄斑变性的视觉功能测量

VISUAL FUNCTION MEASURES IN EARLY AND INTERMEDIATE AGE-RELATED MACULAR DEGENERATION.

作者信息

Chandramohan Arthika, Stinnett Sandra S, Petrowski John T, Schuman Stefanie G, Toth Cynthia A, Cousins Scott W, Lad Eleonora M

机构信息

Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina.

出版信息

Retina. 2016 May;36(5):1021-31. doi: 10.1097/IAE.0000000000001002.

Abstract

PURPOSE

The objectives of this study were to evaluate 1) the feasibility of performing computerized tests of low luminance visual acuity (LLVA), cone-specific contrast (Cone Contrast Test [CCT]), contrast sensitivity, and microperimetry and 2) the test-retest repeatability of these outcomes in dry age-related macular degeneration (AMD).

METHODS

This prospective study enrolled 30 subjects at a single site (8 controls, 8 early AMD, and 12 intermediate AMD). Subjects underwent LLVA, contrast sensitivity, CCT, and microperimetry with eye tracking. Low luminance deficit was defined as best-corrected visual acuity minus LLVA in EDTRS letters. Follow-up testing was administered at approximately 1 month.

RESULTS

There was high test-retest repeatability at one month for all visual function metrics (intraclass correlations >0.7) except log contrast sensitivity (intraclass correlations 0.6). Compared with controls, patients with intermediate AMD showed significant deficits on best-corrected visual acuity, LLVA, low luminance deficit, percent-reduced threshold on microperimetry, and red CCT (P < 0.05), but not on contrast sensitivity, green and blue CCT.

CONCLUSION

This pilot study supports the feasibility and reliability of using LLVA, microperimetry, and CCT in early dry AMD. Our data suggest these measures can be used as alternative future clinical trial endpoints. A larger, prospective natural history study of alternative visual function measures in dry AMD is warranted.

摘要

目的

本研究的目的是评估1)进行低亮度视力(LLVA)、视锥细胞特异性对比度(视锥细胞对比度测试 [CCT])、对比度敏感度和微视野计计算机化测试的可行性,以及2)这些结果在干性年龄相关性黄斑变性(AMD)中的重测重复性。

方法

这项前瞻性研究在单一地点招募了30名受试者(8名对照者、8名早期AMD患者和12名中期AMD患者)。受试者接受了LLVA、对比度敏感度、CCT和带眼动追踪的微视野计检查。低亮度缺陷定义为EDTRS字母表中最佳矫正视力减去LLVA。在大约1个月时进行随访测试。

结果

除对数对比度敏感度(组内相关性为0.6)外,所有视觉功能指标在1个月时均具有较高的重测重复性(组内相关性>0.7)。与对照组相比,中期AMD患者在最佳矫正视力、LLVA、低亮度缺陷、微视野计上降低的阈值百分比和红色CCT方面存在显著缺陷(P<0.05),但在对比度敏感度、绿色和蓝色CCT方面无显著差异。

结论

这项初步研究支持在早期干性AMD中使用LLVA、微视野计和CCT的可行性和可靠性。我们的数据表明,这些测量方法可作为未来临床试验的替代终点。有必要对干性AMD中替代视觉功能测量方法进行更大规模的前瞻性自然史研究。

相似文献

1
VISUAL FUNCTION MEASURES IN EARLY AND INTERMEDIATE AGE-RELATED MACULAR DEGENERATION.
Retina. 2016 May;36(5):1021-31. doi: 10.1097/IAE.0000000000001002.
2
Visual Function Metrics in Early and Intermediate Dry Age-related Macular Degeneration for Use as Clinical Trial Endpoints.
Am J Ophthalmol. 2018 May;189:127-138. doi: 10.1016/j.ajo.2018.02.012. Epub 2018 Mar 15.
3
Longitudinal Evaluation of Visual Function Impairments in Early and Intermediate Age-Related Macular Degeneration Patients.
Ophthalmol Sci. 2022 May 20;2(3):100173. doi: 10.1016/j.xops.2022.100173. eCollection 2022 Sep.
5
Longitudinal Study of Visual Function in Dry Age-Related Macular Degeneration at 12 Months.
Ophthalmol Retina. 2019 Aug;3(8):637-648. doi: 10.1016/j.oret.2019.03.010. Epub 2019 Mar 21.
6
Low-luminance visual acuity and microperimetry in age-related macular degeneration.
Ophthalmology. 2014 Aug;121(8):1612-9. doi: 10.1016/j.ophtha.2014.02.005. Epub 2014 Mar 22.
7
Phase 1 Clinical Trial of Elamipretide in Intermediate Age-Related Macular Degeneration and High-Risk Drusen: ReCLAIM High-Risk Drusen Study.
Ophthalmol Sci. 2021 Dec 22;2(1):100095. doi: 10.1016/j.xops.2021.100095. eCollection 2022 Mar.
9
Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration.
JAMA Ophthalmol. 2015 Apr;133(4):442-8. doi: 10.1001/jamaophthalmol.2014.5963.
10
Association of Visual Function Measures with Drusen Volume in Early Stages of Age-Related Macular Degeneration.
Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):55. doi: 10.1167/iovs.61.3.55.

引用本文的文献

2
Video-evoked neuromarkers of visual function in age-related macular degeneration.
Front Hum Neurosci. 2025 May 1;19:1569282. doi: 10.3389/fnhum.2025.1569282. eCollection 2025.
4
Heterogeneous Visual Function Deficits in Intermediate Age-Related Macular Degeneration: A MACUSTAR Report.
Ophthalmol Sci. 2025 Jan 13;5(4):100708. doi: 10.1016/j.xops.2025.100708. eCollection 2025 Jul-Aug.
8
Bridging the gap of vision restoration.
Front Cell Neurosci. 2024 Nov 21;18:1502473. doi: 10.3389/fncel.2024.1502473. eCollection 2024.
9
[Digital remote monitoring of chronic retinal conditions-A clinical future tool? : Remote monitoring of chronic retinal conditions].
Ophthalmologie. 2024 Oct;121(10):826-834. doi: 10.1007/s00347-024-02109-2. Epub 2024 Sep 14.
10
Prevalence of Age-Related Macular Degeneration in Patients with Chronic Exposure to P2X7R Inhibitors.
Graefes Arch Clin Exp Ophthalmol. 2024 Nov;262(11):3493-3499. doi: 10.1007/s00417-024-06507-9. Epub 2024 May 18.

本文引用的文献

1
Visual Function Endpoints to Enable Dry AMD Clinical Trials.
Drug Discov Today Ther Strateg. 2013 Spring;10(1):e43-e50. doi: 10.1016/j.ddstr.2012.11.002. Epub 2013 Feb 28.
3
Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration.
JAMA Ophthalmol. 2015 Apr;133(4):442-8. doi: 10.1001/jamaophthalmol.2014.5963.
4
Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.
Cell Mol Life Sci. 2014 Dec;71(23):4617-36. doi: 10.1007/s00018-014-1709-x. Epub 2014 Aug 26.
5
Twelve-month natural history of dark adaptation in patients with AMD.
Optom Vis Sci. 2014 Aug;91(8):925-31. doi: 10.1097/OPX.0000000000000247.
6
Low-luminance visual acuity and microperimetry in age-related macular degeneration.
Ophthalmology. 2014 Aug;121(8):1612-9. doi: 10.1016/j.ophtha.2014.02.005. Epub 2014 Mar 22.
7
The prevalence of age-related eye diseases and visual impairment in aging: current estimates.
Invest Ophthalmol Vis Sci. 2013 Dec 13;54(14):ORSF5-ORSF13. doi: 10.1167/iovs.13-12789.
8
Intrasession test-retest variability of microperimetry in age-related macular degeneration.
Invest Ophthalmol Vis Sci. 2013 Nov 11;54(12):7378-85. doi: 10.1167/iovs.13-12617.
9
Clinical classification of age-related macular degeneration.
Ophthalmology. 2013 Apr;120(4):844-51. doi: 10.1016/j.ophtha.2012.10.036. Epub 2013 Jan 16.
10
Impaired mesopic visual acuity in eyes with early age-related macular degeneration.
Invest Ophthalmol Vis Sci. 2012 Oct 23;53(11):7310-4. doi: 10.1167/iovs.11-8649.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验